Sign inJoin waitlistJoin the waitlist

SM

Shannon Morris

Physician · University of North Carolina Hospitals

Credentials: · · ·

History

University of North Carolina Hospitals
Present

Medical Oncology
Internal Medicine

Research

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
The Lancet Oncology · 2012 · 478 citations
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
Annals of Oncology · 2019 · 142 citations
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
Blood · 2014 · 119 citations

Lowell Hart
4 papers
Lisa Carey
3 papers
DD
Davey Daniel
2 papers
David Hong
2 papers
DR
Donald Richards
2 papers
HB
Howard Burris
2 papers
JB
J Beck
2 papers
Jared Weiss
2 papers
JI
Jeffrey Infante
2 papers
JG
Jerome Goldschmidt
2 papers
Konstantin Dragnev
2 papers
Maen Hussein
2 papers